Pro-lymphocytic leukemia

Clinical trials for Pro-lymphocytic leukemia explained in plain language.

Never miss a new study

Get alerted when new Pro-lymphocytic leukemia trials appear

Sign up with your email to follow new studies for Pro-lymphocytic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Lower drug dose after transplant may cut infections without losing protection

Disease control Ongoing

This study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant from a partially matched donor, can reduce serious infections in the first 100 days while still preventing graft-versus-host disease (a common complication where donor cells att…

Matched conditions: PRO-LYMPHOCYTIC LEUKEMIA

Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC

Pro-lymphocytic leukemia

Get alerted when new Pro-lymphocytic leukemia trials appear

Lower drug dose after transplant may cut infections without losing protection